Artivion Executive and Leadership Team

J. Mackin, the Chairman, President & Chief Executive Officer at Artivion, directs the overarching corporate strategy for this global medical technology leader. Mackin oversees the development and distribution of cardiac and vascular devices, ensuring alignment between manufacturing capabilities and the evolving needs of surgeons worldwide. By architecting long-term growth initiatives, the Chairman, President & Chief Executive Officer drives the expansion of the aortic disease treatment portfolio. This leadership role involves constant collaboration with the Board to maintain market competitiveness and financial health. J. Mackin monitors the integration of surgical sealants and stent grafts into international markets, securing the company's position as a premier provider of implantable tissues. Through rigorous oversight of organizational performance, the Chairman, President & Chief Executive Officer ensures that all business units remain focused on delivering high-quality patient outcomes across diverse geographic regions.

Lance Berry, the Executive Vice President & Chief Operating Officer & Chief Financial Officer at Artivion, manages the complex intersection of financial planning and operational execution. Berry optimizes the manufacturing processes for heart valves and surgical sealants, ensuring that supply chain logistics support global demand. As the Executive Vice President & Chief Operating Officer & Chief Financial Officer, Berry maintains fiscal discipline while scaling production capacity to meet the requirements of surgeons in North America and beyond. This role involves analyzing capital allocation strategies to fund research into advanced aortic disease solutions. Lance Berry coordinates with internal departments to streamline operational workflows, thereby increasing efficiency and reducing overhead costs. By balancing financial stability with operational agility, the Executive Vice President & Chief Operating Officer & Chief Financial Officer supports the broader mission of delivering life-saving medical technologies to patients in need of specialized vascular care.

Simona Zannetti, the Senior VP, Clinical Research & Chief Medical Officer at Artivion, leads the scientific validation of innovative aortic disease treatments. Zannetti oversees the design and execution of clinical trials, ensuring that all cardiac and vascular devices meet the highest safety and efficacy standards. As the Senior VP, Clinical Research & Chief Medical Officer, Zannetti collaborates with global surgical partners to gather real-world evidence on implantable tissues and stent grafts. This leadership position requires constant engagement with regulatory bodies to facilitate the approval of new medical technologies. Simona Zannetti drives the clinical strategy, ensuring that research initiatives directly translate into improved patient outcomes. By managing the clinical research pipeline, the Senior VP, Clinical Research & Chief Medical Officer provides the necessary data to support the adoption of advanced surgical solutions across international healthcare systems, ultimately strengthening the company's reputation for medical excellence.

Marshall Stanton, the Senior Chief Medical Officer, Vice President , Clinical Research at Artivion, focuses on the medical integrity and clinical application of the company's diverse product line. Stanton evaluates the performance of heart valves and surgical sealants, providing critical medical insights that guide product development cycles. As the Senior Chief Medical Officer, Vice President , Clinical Research, Stanton manages the medical affairs team to ensure that surgeons receive comprehensive support and training for complex aortic procedures. This role involves analyzing clinical data to identify opportunities for technological refinement and innovation. Marshall Stanton coordinates with the research department to prioritize projects that address unmet needs in vascular medicine. By bridging the gap between clinical practice and manufacturing, the Senior Chief Medical Officer, Vice President , Clinical Research ensures that every device produced aligns with the highest standards of patient care and surgical efficacy in global markets.